Does dual HER-2 blockade treatment increase the risk of severe toxicities of special interests in breast cancer patients: A meta-analysis of randomized controlled trials

Although dual HER-2 blockade treatment could offer greater clinical efficacy in breast cancer, the risk of severe toxicities of special interest related to this combined regimen in breast cancer remained unknown. We systematically searched public databases (MEDLINE, EMBASE, Cochrane library) to iden...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Hao, Shuai, Tian, Wuguo, Gao, Bo, Jiang, Yan, Zhang, Xiaohua, Zhang, Shu, Guo, Lingji, Zhao, Jianjie, Zhang, Gang, Hu, Chunyan, Yan, Jie, Luo, Donglin
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5386734/
https://ncbi.nlm.nih.gov/pubmed/28199966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15252
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados